CG
INO icon

Colony Group’s Inovio Pharmaceuticals INO Stock Holding History

Colony Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-174
Closed -$14K – 429
2015
Q4 		$14K Hold
174
– – ﹤0.01% 586
2015
Q3 		$12K Sell
174
-66
-28% -$5.75K ﹤0.01% 599
2015
Q2 		$23K Hold
240
– – ﹤0.01% 529
2015
Q1 		$23K Hold
240
– – ﹤0.01% 497
2014
Q4 		$26K Hold
240
– – ﹤0.01% 506
2014
Q3 		$28K Buy
240
+167
+229% +$20.8K ﹤0.01% 487
2014
Q2 		$9K Buy
+73
New +$8.62K ﹤0.01% 534

Other funds holding INO

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Colony Group's INO Position: Q1 2016 in Review

Colony Group sold out of Inovio Pharmaceuticals (INO) in Q1 2016, closing a stake of 174 shares — an estimated $14K sold.

Colony Group first reported a position in INO in Q2 2014 and held it in 7 quarters. The position peaked at $28K in Q3 2014. 115 funds tracked by Wall St. Rank hold INO as of Q1 2016.

  • Colony Group reported no remaining Inovio Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Colony Group sold 174 Inovio Pharmaceuticals shares in Q1 2016, an estimated $14K.
  • Colony Group first reported a position in Inovio Pharmaceuticals in Q2 2014 and held it in 7 quarters.
  • Colony Group's Inovio Pharmaceuticals position peaked at $28K in Q3 2014.
  • 115 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2016.

Based on Colony Group's 13F filing for Q1 2016, filed 16 May 2016.